Company / Accounts Receivable
Inspire Medical Systems, Inc. Accounts Receivable History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$119.7M
FY2025
5-year range
$34.2M / $119.7M
FY2021-FY2025
Trend
+28.6%
vs FY2024
Sector context
#88 of 138
Health Care
What the data says
At $120M, Inspire Medical Systems, Inc.'s accounts receivable ranks #88 of 138 in the Health Care sector. Accounts Receivable has increased for 8 consecutive years, from $4M in FY2017 to $120M in FY2025.
Based on SEC 10-K filings.
$120M in FY2025 with a 5-year CAGR of +36.7%.
Improved from $90M to $120M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +25.0%
- 5-Year CAGR
- +36.7%
- 10-Year CAGR
- -
Sector benchmark
#88 of 138 in Health CareTop 64% of 138This company $119.7M Sector average $1.3B
▼
-90.9% below sector average
Key checks
Key Insights
- Inspire Medical Systems, Inc.'s accounts receivable has grown for 8 consecutive years.
- 5-year CAGR of +36.7%, indicating consistent growth.
- In FY2025, accounts receivable increased 28.6% year-over-year.
- Ranks #88 out of 138 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 4.03 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $119.7M | +28.6% |
| FY2024 | $93.1M | +3.5% |
| FY2023 | $89.9M | +46.8% |
| FY2022 | $61.2M | +79.1% |
| FY2021 | $34.2M | +36.4% |
| FY2020 | $25.1M | +90.9% |
| FY2019 | $13.1M | +97.0% |
| FY2018 | $6.7M | +72.8% |
| FY2017 | $3.9M | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026